22.12.2016
- After US healthcare company Johnson & Johnson bowed out of the race to strike a deal with Swiss biotech-pharmaceuticals company Actelion, and Sanofi was reported to have launched...
15.12.2016
- Johnson & Johnson has withdrawn from the running for Actelion Pharmaceuticals, leaving the path clear for another buyer, which multiple reports say is Sanofi. The US healthcare...
15.12.2016
- Drugmaker Sanofi is facing a class action suit brought by French parents who allege their children suffered birth defects because their mothers took the company’s anticonvulsant...
12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
07.12.2016
- French drugs major Sanofi is weighing a rival offer to Johnson & Johnson’s recent bid for Swiss pharmaceuticals and biotech firm Actelion, the news agency Bloomberg has reported...
06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
30.11.2016
- The splash-making news that Swiss pharmaceuticals and biotechnology firm Actelion is holding preliminary talks with major US healthcare company Johnson & Johnson (J&J) about a...
29.11.2016
- Major US healthcare company Johnson & Johnson (J&J) is holding preliminary talks with Swiss pharmaceuticals and biotechnology firm Actelion about a potential takeover. An...
15.11.2016
- Sanofi and US biopharmaceutical company Mannkind have finally thrashed out an agreement to terminate their licensing deal for Afrezza inhalable insulin. The agreement will likely...
10.11.2016
- Shares in major globally active pharmaceutical producers rose by as much as 11% on the news that Donald Trump had won the Nov. 8 election as president of the United States. The...
